Retrospective Multicenter Long-Term Follow-up Analysis of Prognostic Risk Factors for Recurrence-Free, Metastasis-Free, Cancer-Specific, and Overall Survival After Curative Nephrectomy in Non-metastatic Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Retrospective Multicenter Long-Term Follow-up Analysis of Prognostic Risk Factors for Recurrence-Free, Metastasis-Free, Cancer-Specific, and Overall Survival After Curative Nephrectomy in Non-metastatic Renal Cell Carcinoma

Published:2019-09-04 Issue: Volume:9 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Kim Sung Han,Park Boram,Hwang Eu Chang,Hong Sung-Hoo,Jeong Chang Wook,Kwak Cheol,Byun Seok Soo,Chung Jinsoo

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference29 articles.

1. ICUD-EAU International Consultation on Kidney Cancer 2010: treatment of metastatic disease;Patard;Eur Urol,2011

2. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012;Ferlay;Eur J Cancer,2013

3. Continued increase in incidence of renal cell carcinoma, especially in young patients and high grade disease: United States 2001 to 2010;King;J Urol.,2014

4. Renal cell carcinoma: risk assessment and prognostic factors for newly diagnosed patients;Downs;Crit Rev Oncol Hematol,2009

5. Beyond gastric adenocarcinoma: Multimodality assessment of common and uncommon gastric neoplasms;Richman;Abdom Radiol (NY),2017

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renin-angiotensin-system and clear cell renal carcinoma: research advances and future perspectives;Journal of Cancer Metastasis and Treatment;2024-08-30

2. Recurrence patterns following nephrectomy for renal cell carcinoma in a Danish nationwide cohort;BJUI Compass;2024-06-10

3. Analysis of HIF-1α expression and genetic polymorphisms in human clear cell renal cell carcinoma;Pathology and Oncology Research;2024-01-11

4. Cost-effectiveness of Nivolumab Plus Cabozantinib Versus Cabozantinib as First-Line Treatment of Metastatic Renal Cell Carcinoma;Clinical Genitourinary Cancer;2023-12

5. Applications of nanofibers drug delivery system in cancer therapy;Journal of Drug Delivery Science and Technology;2023-12